289 related articles for article (PubMed ID: 22417013)
1. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T
BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 and its ligand CXCL12 display opposite expression profiles in feline mammary metastatic disease, with the exception of HER2-overexpressing tumors.
Marques CS; Santos AR; Gameiro A; Correia J; Ferreira F
BMC Cancer; 2018 Jul; 18(1):741. PubMed ID: 30012106
[TBL] [Abstract][Full Text] [Related]
3. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
4. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
5. Role of CXCR4 and SDF-1 in mammary tumor metastasis in the cat.
Oonuma T; Morimatsu M; Nakagawa T; Uyama R; Sasaki N; Nakaichi M; Tamamura H; Fujii N; Hashimoto S; Yamamura H; Syuto B
J Vet Med Sci; 2003 Oct; 65(10):1069-73. PubMed ID: 14600343
[TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR4 axis in feline mammary carcinoma.
Ferreira F
Aging (Albany NY); 2017 Dec; 9(12):2457-2458. PubMed ID: 29232654
[No Abstract] [Full Text] [Related]
7. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours.
Petterino C; Podestà G; Ratto A; Drigo M; Pellegrino C
Vet Res Commun; 2007 Feb; 31(2):173-84. PubMed ID: 17186410
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
[TBL] [Abstract][Full Text] [Related]
9. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Faustino A; Dias Pereira P
J Comp Pathol; 2014; 150(2-3):169-74. PubMed ID: 24220012
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
14. Complex carcinomas of the mammary gland in cats: pathological and immunohistochemical features.
Seixas F; Pires MA; Lopes CA
Vet J; 2008 May; 176(2):210-5. PubMed ID: 17459738
[TBL] [Abstract][Full Text] [Related]
15. Expression of Stat3 in feline mammary gland tumours and its relation to histological grade.
Petterino C; Ratto A; Arcicasa E; Podestà G; Drigo M; Pellegrino C
Vet Res Commun; 2006 Aug; 30(6):599-611. PubMed ID: 16838202
[TBL] [Abstract][Full Text] [Related]
16. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
Millanta F; Asproni P; Canale A; Citi S; Poli A
Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
[TBL] [Abstract][Full Text] [Related]
17. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
18. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
19. Aberrant subcellular immunolocalization of NOTCH-1 activated intracellular domain in feline mammary tumours.
Ressel L; Else RW; Poli A; Argyle DJ
J Comp Pathol; 2014 May; 150(4):366-72. PubMed ID: 24529510
[TBL] [Abstract][Full Text] [Related]
20. Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma.
Tanabe S; Nakadai T; Furuoka H; Oomachi T; Kobayashi Y; Omata Y; Koyama T; Hondo E; Uzuka Y; Sarashina T; Ducusin RJ; Shida T; Dorf ME
Vet Rec; 2002 Dec; 151(24):729-33. PubMed ID: 12509077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
